BSE IT Technology Sector Regulatory Filings — March 23, 2026

Allotted 200,596 ESOP shares (35,549 under 2015 Plan, 165,047 under 2019 Program) on March 23, 2026, increasing share capital to 4,05,55,91,723 shares; negligible 0.005% dilution reflects strong employee conviction in long-term growth

Board resolution on March 18, 2026, for ESOP exercise under established plans indicates robust talent retention trends vs. sector peers, with neutral sentiment but positive insider-aligned incentives

Scheduled board meeting April 9, 2026, for FY26 audited standalone/consolidated results; potential final dividend recommendation signals capital allocation continuity [NEUTRAL/BULLISH]

Trading window closure from March 24, 2026, until 48 hours post-results enforces compliance, highlighting disciplined governance amid earnings anticipation

Launched new AI-led Innovation Lab in Seoul as part of WIN network, expanding office footprint in strategic South Korea market; positive sentiment (7/10)

Builds on 2025 HARMAN DTS acquisition adding 5,000+ professionals, now operating 9 global innovation facilities (5 in APMEA) with hundreds in South Korea

Focus on AI transformation in technology, automotive, industrial sectors via local presence and global delivery network; partnerships for talent upskilling enhance operational metrics

2/3 filings neutral/positive sentiment (Infosys/TCS neutral at 4-7/10, Wipro positive 7/10), no adverse period trends reported, underscoring BSE IT sector resilience

31st AGM upcoming post-April 9 board for dividend approval, consistent with historical capital returns favoring shareholders

South Korea positioned as strategic growth market, with enlarged Seoul footprint signaling QoQ operational expansion vs. stagnant peers

ESOP allotment per March 18 board resolution effective March 23, minimal impact on financial ratios like debt-to-equity (unchanged)

ESOP allotment of 200,596 shares increases issued capital to ₹20,27,79,58,615; though only 0.005% dilution, repeated allotments could pressure EPS over time

Closure from March 24, 2026, until post-April 9 results limits liquidity and signals potential volatility around FY26 earnings

Final dividend 'if any' recommendation pending April 9 board; any cut vs. prior years would flag capital allocation concerns

Materiality 4/10 with no forward guidance or operational metrics; lacks bullish catalysts compared to Wipro's expansion

Audited FY26 results (ending March 31) scheduled April 9; any delays or misses in revenue/margins could amplify sector downturns

Post-2025 HARMAN DTS acquisition (5,000+ pros), new Seoul lab execution risks in competitive AI/tech sectors if upskilling partnerships underperform

No insider trading activity reported in any filing, potentially indicating low management conviction amid closed windows

New Seoul AI Lab targeting tech/auto/industrial; leverage APMEA focus (5/9 global labs) for 20-30% regional growth outperformance

Enlarged South Korea footprint post-HARMAN DTS; trade ahead of client wins in high-growth market, positive sentiment 7/10

April 9, 2026, board for FY26 results/dividend; position for margin beats or dividend hike vs. sector, materiality 7/10

200,596 shares allotted under proven plans; alpha from employee-aligned growth, negligible dilution supports buy-the-dip

Potential final dividend at 31st AGM; historical yields offer income play, watch vs. reinvestment in peers like Wipro

5,000+ pros from 2025 acquisition fueling Innovation Network; undervalued AI exposure vs. BSE IT averages

ESOP exercise (2015/2019 plans) signals lower attrition risk; relative outperformance in human capital metrics

Trading window discipline enhances governance premium; opportunity pre-results for long-only positioning

Infosys allotment of 200,596 shares (0.005% dilution) highlights talent retention trend; 1/3 filings show employee ownership conviction amid competition

TCS April 9, 2026, FY26 results board meeting sets sector tone; trading window closures signal Q4 focus across BSE IT

Wipro's South Korea push (new lab, post-HARMAN) vs. neutral updates in peers; 1/3 positive on APMEA growth, AI in tech/auto/industrial

TCS dividend pending (vs. Infosys dilution neutral); sector leans shareholder returns pre-AGM, no buybacks noted

2/3 filings neutral (Infosys 4/10, TCS 7/10), 1 positive (Wipro 7/10); no margin/revenue QoQ declines, steady operational metrics

No new M&A (Wipro references 2025 HARMAN); focus shifts to organic labs/partnerships, low valuation risks in deals

FY26 audited results and dividend recommendation; monitor for revenue guidance, margin trends on April 9, 2026

Closed until 48 hours post-results announcement; watch re-opening for insider activity spikes post-April 9

Shareholder approval of final dividend post-April board; track record date and yield vs. historicals

Seoul AI Lab rollout and client partnerships; monitor Q1 FY27 updates for volumes/costs from tech/auto/industrial focus

Employment ramp-up (hundreds of pros) and academic upskilling; watch for deal announcements building on HARMAN DTS

Ongoing 2015/2019 plan allotments; track next board resolutions for dilution cumulative impact and holdings changes

No transactions reported; monitor for pledges/sales post-TCS window re-open in CEOs/CFOs